Insmed
INSM
#899
Rank
C$38.28 B
Marketcap
C$174.50
Share price
-0.83%
Change (1 day)
-37.08%
Change (1 year)

P/S ratio for Insmed (INSM)

P/S ratio as of November 2026 (TTM): 17.6

According to Insmed's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 36.8. At the end of 2026 the company had a P/S ratio of 16.0.

P/S ratio history for Insmed from 2001 to 2026

PS ratio at the end of each year

Year P/S ratio Change
202616.0-74.37%
202562.381.92%
202434.2135.72%
202314.531.67%
202211.0-35.52%
202117.1-17.05%
202020.631.43%
201915.7-84.78%
2018103
2017N/A
2016N/A
2015N/A
2014N/A-100%
201357.9
2012N/A-100%
201117.120.19%
201014.347.61%
20099.67101.06%
20084.81-64.28%
200713.5-85.03%
200689.9-91.02%
2005> 100038.83%
2004721-5.21%
20037609874.26%
20027.62-98.21%
2001425

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
Novartis
NVS
5.24-70.22%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Gilead Sciences
GILD
6.82-61.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
10.5-40.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
0.8022-95.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
3.52-79.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Array Technologies
ARRY
0.5416-96.92%๐Ÿ‡บ๐Ÿ‡ธ USA